CID 6446989

11-((4-cinnamyl-1-piperzinyl)acetyl)-5,11-dihydro-6h-pyrido(2,3-b)(1,4)benzodiazepin-6-one

Structural Information

Molecular Formula
C27H27N5O2
SMILES
C1CN(CCN1C/C=C/C2=CC=CC=C2)CC(=O)N3C4=CC=CC=C4C(=O)NC5=C3N=CC=C5
InChI
InChI=1S/C27H27N5O2/c33-25(20-31-18-16-30(17-19-31)15-7-10-21-8-2-1-3-9-21)32-24-13-5-4-11-22(24)27(34)29-23-12-6-14-28-26(23)32/h1-14H,15-20H2,(H,29,34)/b10-7+
InChIKey
WDYOLFBUUJYHSP-JXMROGBWSA-N
Compound name
11-[2-[4-[(E)-3-phenylprop-2-enyl]piperazin-1-yl]acetyl]-5H-pyrido[2,3-b][1,4]benzodiazepin-6-one
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

1
Patents

453.21646 Da
Monoisotopic Mass

2.2
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 454.22374 216.2
[M+Na]+ 476.20568 228.5
[M+NH4]+ 471.25028 220.5
[M+K]+ 492.17962 220.9
[M-H]- 452.20918 219.2
[M+Na-2H]- 474.19113 221.2
[M]+ 453.21591 218.7
[M]- 453.21701 218.7
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

patents stripe